About Lukas Biomedical
Lukas Biomedical is a company based in Taiwan founded in 2017. It operates as a B2B. Lukas Biomedical operates in a competitive market with competitors including Redbud Medicine, OncoTheis, AlphaVax, DXOCRO and Oncosyne, among others.
- Headquarter Taiwan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lukas Biomedical
Detailed funding history for Lukas Biomedical
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lukas Biomedical
Investment portfolio details for Lukas Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lukas Biomedical
Detailed financials for Lukas Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lukas Biomedical Comparisons
Peer comparison for Lukas Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lukas Biomedical
Lukas Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Redbud Medicine, OncoTheis, AlphaVax, DXOCRO and Oncosyne, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Offers comprehensive services in regulatory affairs, R&D, data management, and statistical analysis for healthcare.
|
|
| Locked | Locked | Locked |
Provides 3D tissue testing services for in-vitro lung cancer drug testing.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases and cancer immunotherapy are developed.
|
|
| Locked | Locked | Locked |
Provides in vitro diagnostic services for oncology research and development.
|
|
| Locked | Locked | Locked |
Offers tumoroid-based platforms for cancer drug screening and personalized medicine services.
|
Detailed competitors of Lukas Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lukas Biomedical
Complete news archive for Lukas Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lukas Biomedical
Lukas Biomedical was founded in 2017.
Lukas Biomedical is headquartered in Taiwan.
Lukas Biomedical, established in 2017, excels in providing healthcare solutions, advancing biotech innovations, cancer treatment, and immunotherapy. A biotechnology company developing autologous immune cell therapies to treat various types of cancer. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Lukas Biomedical's top competitors include Ontogen, AlphaVax and Cancer Research For Oza Rks.